Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Epanutin

- PMLiVE

Dawn of the new world

What the new NHS means for pharma and healthcare comms

- PMLiVE

McCarthy leaves NHS England

Policy director set for move to the University of Bradford

- PMLiVE

FDA approves new indication for Pfizer/BMS’ Eliquis

Oral anticoagulant gains US approval for deep vein thrombosis use

UK flag

UK gets its own ‘breakthrough’ status for early medicines access

But concerns remain over funding

- PMLiVE

Teva backs UK’s dementia drive with $21m investment

Pharma company will support National Institute for Health Research

National Institute for Health and Care Excellence NICE logo

NICE denies pharma influence on statin guidance

Responds to accusations committee members were ‘in the pay’ of drug firms

National Institute for Health and Care Excellence NICE logo

NICE denies pharma influence on statin guidance

Responds to accusations committee members were ‘in the pay’ of drug firms

- PMLiVE

Pfizer 2014 guidance threatened by Celebrex competition

Court overturns key patent for osteoarthritis drug

- PMLiVE

Pfizer still number one – just

The PMLiVE Top Pharma List is updated with a ranking of the 25 biggest companies in the industry

- PMLiVE

AZ launches combination diabetes drug in UK

Xigduo combines Forxiga and metformin

NICE and ‘ultra orphans’

NICE and its processes for ‘highly specialised therapies’

- PMLiVE

Pfizer recalls depression drug in US

Wrong medicine found in bottle of Effexor XR

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links